MiR-103-3p targets the m6 A methyltransferase METTL14 to inhibit osteoblastic bone formation.
Ontology highlight
ABSTRACT: Impaired osteoblast function is involved in osteoporosis, and microRNA (miRNA) dysregulation may cause abnormal osteoblast osteogenic activity. However, the influence of miRNA on osteoblast activity and the underlying mechanisms remain elusive. In this study, miR-103-3p was found to be negatively correlated with bone formation in bone specimens from elderly women with fractures and ovariectomized (OVX) mice. Additionally, miR-103-3p directly targeted Mettl14 to inhibit osteoblast activity, and METTL14-dependent N6 -methyladenosine (m6 A) methylation inhibited miR-103-3p processing by the microprocessor protein DGCR8 and promoted osteoblast activity. Moreover, miR-103-3p inhibited bone formation in vivo, and therapeutic inhibition of miR-103-3p counteracted the decreas
SUBMITTER: Sun Z
PROVIDER: S-EPMC7884043 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA